Illuminate Therapeutics
Updated: March 25, 2026
Founder Daniel Hayes
Country: USA | Add Funding
Founded: 2024
Illuminate Therapeutics is a spin-off of Pennsylvania State University developing an effective and targeted treatment for head and neck cancer that will cause minimal damage to surrounding healthy tissue. The potential treatment utilizes Illuminate's drug delivery and release platform based on light-activated nanoparticles (LADDR). It uses very focused laser to activate a light sensitive nanoparticle that delivers a nucleic acid that would target many different genes within the cancer cell. Such a precise methodology enables to use more potent chemicals to target the cancer cell.
Founded: 2024
Illuminate Therapeutics is a spin-off of Pennsylvania State University developing an effective and targeted treatment for head and neck cancer that will cause minimal damage to surrounding healthy tissue. The potential treatment utilizes Illuminate's drug delivery and release platform based on light-activated nanoparticles (LADDR). It uses very focused laser to activate a light sensitive nanoparticle that delivers a nucleic acid that would target many different genes within the cancer cell. Such a precise methodology enables to use more potent chemicals to target the cancer cell.
